300
Tower Parkway
Lincolnshire, Illinois 60069
March 12, 2004
DEAR STOCKHOLDER:
The Fortune Brands, Inc. 2004 Annual Meeting of Stockholders will be held at 1:30 p.m. (Central Daylight Time) on Tuesday, April 27, 2004 at the Marriott Lincolnshire, 10 Marriott Drive, Lincolnshire, Illinois. The sole purpose of the meeting is to consider the business described in the following Notice of Annual Meeting and Proxy Statement.
It is important to ensure that your shares be represented at the meeting, whether or not you personally plan to attend. You can submit your proxy by using a toll-free telephone number or the Internet. Instructions for using these services are provided on the enclosed proxy form. If you decide to vote your shares using the enclosed proxy form, we urge you to complete, sign, date and return it promptly, using the enclosed postage paid return envelope.
Sincerely,
Norman H.
Wesley
Chairman of the Board
and Chief Executive Officer
300
Tower Parkway
Lincolnshire, Illinois 60069
NOTICE
OF ANNUAL MEETING
AND PROXY STATEMENT
March 12, 2004
The Annual Meeting of Stockholders of Fortune Brands, Inc. (Fortune Brands or the Company) will be held at the Marriott Lincolnshire, 10 Marriott Drive, Lincolnshire, Illinois, at 1:30 p.m. (Central Daylight Time) on Tuesday, April 27, 2004, to consider and vote upon:
Item 1: | The election of three directors for a term expiring at the 2007 Annual Meeting or until their successors have been elected and qualified (see pages 3 to 23 of the Proxy Statement); |
Item 2: | The ratification of the appointment by the Companys Audit Committee of PricewaterhouseCoopers LLP as our independent auditors for 2004 (see page 23 of the Proxy Statement); |
Item 3: | If presented, a stockholder proposal entitled Shareholder Vote on Poison Pills (see pages 23 to 26 of the Proxy Statement); |
and to transact such other business as may properly come before the meeting.
If you hold common stock or $2.67 Convertible Preferred stock at the close of business on February 27, 2004, you will be entitled to vote at the Annual Meeting. Please submit a proxy as soon as possible so that your shares can be voted at the meeting in accordance with your instructions. You may submit your proxy (1) by telephone, (2) through the Internet, or (3) by mail. For specific instructions, please refer to the next page of this Proxy Statement and the enclosed proxy form.
We are also soliciting voting instructions from participants in the Fortune Brands Retirement Savings Plan, Fortune Brands Hourly Employee Retirement Savings Plan and Future Brands LLC Retirement Savings Plan who have invested in the Fortune Brands Stock Fund. We ask each plan participant to sign, date and return the enclosed proxy card, or provide voting instructions by telephone or through the Internet. The proxy card will serve as a voting instruction card when we forward it to the trustee.
Mark A. Roche
Senior Vice
President, General Counsel
and Secretary
This Proxy Statement and accompanying proxy are being distributed on or about March 12, 2004.
VOTING AND PROXIES
What is the purpose of the Annual Meeting?
Who is entitled to vote?
What is the difference between being a record holder and holding shares in street name?
How do I vote?
How will my proxy be voted?
What if I dont mark the boxes on my proxy?
|
the election of directors; |
|
the ratification of the appointment of PricewaterhouseCoopers LLP as our independent auditors for 2004; and |
|
the stockholder proposal entitled Shareholder Vote on Poison Pills. |
2
Can I go to the Annual Meeting if I vote by proxy?
Will my vote be public?
What constitutes a quorum?
How many votes are needed to approve an Item?
What if I am a participant in the Fortune Brands Retirement Savings Plan, the Fortune Brands Hourly Employee Retirement Savings Plan, or the Future Brands LLC Retirement Savings Plan?
Item 1
ELECTION OF DIRECTORS
3
Name |
Present positions and offices with the Company, principal occupations during the past five years and other directorships |
Age |
Year first elected director |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NOMINEES FOR DIRECTORS CLASS III DIRECTORS TERM EXPIRING 2007 |
||||||||||||||
Anne M. Tatlock |
Chairman and Chief Executive Officer of Fiduciary Trust Company International (global investment management services) since 2000; President
and Chief Executive Officer of Fiduciary Trust Company International prior thereto. A Director and Vice Chairman of Franklin Resources, Inc. Also a
director of American General Corporation and Merck & Co., Inc. |
64 | 1996 | |||||||||||
Norman H. Wesley |
Chairman of the Board and Chief Executive Officer of Fortune Brands, Inc. since December 1999; President and Chief Operating Officer of
Fortune Brands, Inc. prior thereto. Also a director of R.R. Donnelley & Sons Company and Pactiv Corporation. |
54 | 1999 | |||||||||||
Peter M. Wilson |
Retired since March 2004; Chairman of Gallaher Group Plc (tobacco products) from January 2000 to March 2004; Chairman and Chief Executive of
Gallaher Group Plc prior thereto. Also a director of Kesa Electricals plc and Somerfield plc. |
62 | 1994 | |||||||||||
CLASS I DIRECTORS TERM EXPIRING 2005 |
||||||||||||||
Thomas C. Hays |
Retired since December 1999; Chairman of the Board and Chief Executive Officer of Fortune Brands, Inc. prior thereto. |
68 | 1981 | |||||||||||
Gordon R. Lohman |
Retired since 1999; Chairman and Chief Executive Officer of Amsted Industries Incorporated (railroad, construction and building market
products) prior thereto. Also a director of Ameren Corporation. |
69 | 1990 |
4
Name |
Present positions and offices with the Company, principal occupations during the past five years and other directorships |
Age |
Year first elected director | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J. Christopher Reyes |
Co-Chairman of Reyes Holdings, L.L.C. (food and beverage distributor). Mr. Reyes is also a director of The Allstate Corporation and Wintrust
Financial Corporation. |
50 | 2002 | |||||||||||
Pierre E. Leroy |
President, Worldwide Construction & Forestry Division and Worldwide Parts Division of Deere & Company (farming and lawn care product
manufacturer) since December 2003; President, Worldwide Construction & Forestry Division and John Deere Power Systems from 2000 to December 2003;
President, Worldwide Construction Equipment Division of Deere & Company prior thereto. |
55 | 2003 | |||||||||||
CLASS II DIRECTORS TERM EXPIRING 2006 |
||||||||||||||
Patricia O. Ewers |
Retired since July 2000; President of Pace University prior thereto. |
68 | 1991 | |||||||||||
Eugene A. Renna |
Retired since January 2002; Executive Vice President of Exxon Mobil Corporation (oil and petroleum products) from December 1999 to January
2002; President and Chief Operating Officer of Mobil Corporation prior thereto. Also a director of Ryder System, Inc. and AK Steel Holding
Corporation. |
59 | 1998 | |||||||||||
David M. Thomas |
Chairman of the Board and Chief Executive Officer of IMS Health Incorporated (pharmaceutical and healthcare information solution provider)
since 2000; Senior Vice President and Group Executive of the Personal Systems Group of International Business Machines Corporation prior thereto. Mr.
Thomas is also a director of The Trizetto Group, Inc. and The MONY Group Inc. |
54 | 2000 |
5
Director Independence
Audit Committee Financial Expert
Stockholder Communication
Annual Meeting Attendance
6
Committees
Executive Committee |
||||||||||
Members |
Messrs. Hays, Lohman, Wilson and Wesley and Mrs. Tatlock |
|||||||||
Number of
Meetings Last Year |
One |
|||||||||
Primary
Functions |
Has
all the power of the full Board except for specific powers which by law must be exercised by the full Board. |
|||||||||
Audit Committee |
||||||||||
Members |
Messrs. Leroy, Reyes and Thomas and Mrs. Tatlock |
|||||||||
Number of
Meetings Last Year |
Four (The Committee also had several teleconferences to review and discuss press releases and quarterly SEC reports.) |
|||||||||
Primary
Functions |
1. Retains, subject to stockholder ratification, a firm of independent auditors to audit our financial statements and
approves the scope of the firms audit; 2. Reviews reports and recommendations of our independent auditors; 3. Reviews the scope of all internal audits and related reports and recommendations; 4. Pre-approves all audit and non-audit services provided by our independent auditors; 5. Monitors integrity of financial statements; 6. Monitors compliance with financial reporting requirements; 7. Monitors the independence and performance of our independent auditors and the performance of our internal auditors; 8. Discusses the Companys financial statements and its quarterly and annual reports to be filed with the Securities Exchange Commission (the SEC); 9. Reviews the Companys policies regarding risk assessment and risk management; and 10. Establishes procedures for receiving and responding to concerns regarding accounting and auditing matters. |
|||||||||
Compensation and Stock Option Committee |
||||||||||
Members |
Messrs. Lohman, Renna and Reyes and Dr. Ewers |
|||||||||
Number of
Meetings Last Year |
Five |
|||||||||
Primary
Functions |
1. Administers our Long-Term Incentive Plans; 2. Designates key employees who may be granted stock options, performance awards and other stock-based awards; 3. Designates the number of shares that may be granted to a key employee, within specified limits; 4. Reviews and approves compensation and goals for the chief executive officer and evaluates his or her performance, in consultation with the Companys independent directors; |
7
5. Sets compensation for our officers who hold the office of Vice President or a more senior office and recommends compensation
levels for the Chief Executive Officers of our operating subsidiaries; 6. Determines the incentive compensation award for those senior officers under the Annual Executive Incentive Compensation Plan; 7. Retains any compensation consultants to assist in the evaluation of senior executive compensation and benefits; and 8. Oversees managements administration of supplemental retirement and other benefit arrangements, compensation agreements and severance agreements for executive officers. |
||||||||||
Nominating and Corporate Governance Committee |
||||||||||
Members |
Messrs. Leroy, Lohman, Renna and Thomas and Mrs. Tatlock |
|||||||||
Number of
Meetings Last Year |
Four |
|||||||||
Primary
Functions |
1. Recommends nominees for election as members of the Board of Directors; 2. Recommends directors for membership on the Audit Committee, Compensation and Stock Option Committee and Nominating and Corporate Governance Committee, including their Chairmen; 3. Recommends directors and executive officers for membership on other committees established by the Board of Directors; 4. Recommends compensation arrangements for non-employee directors; 5. Develops and recommends a set of corporate governance principles designed to foster an effective corporate governance environment; 6. Administers our 2002 Non-Employee Director Stock Option Plan and the Stock Plan for Non-employee Directors; 7. Reviews the charters of Board committees; and 8. Manages the performance review process of the Board, its committees and management. |
|||||||||
Corporate Responsibility Committee |
||||||||||
Members |
Dr.
Ewers, Messrs. Hays, Wilson and Mr. Clarkson Hine (Vice President-Corporate Communications) |
|||||||||
Number of
Meetings Last Year |
Four |
|||||||||
Primary
Functions |
Reviews and recommends to the Board policies on the Companys responsibilities to its employees and the community, such as: employee
safety, diversity and equal opportunity; philanthropic activities; and the effect of Company operations on the environment. |
Nomination Process
8
director qualifications as well as criteria for director independence and the selection of director candidates to be recommended to the Board.
Director Compensation
9
(i) |
the option price per share shall not be less than fair market value at the time the option is granted; |
(ii) |
the option does not become exercisable until the holder has been a director for at least one year after the date of grant (except in the case of death or a change in control of Fortune Brands, Inc.) and may generally be exercised for 10 years from the date of grant; |
(iii) |
if the holder ceases to be a director by reason of death, disability or retirement after five or more years of service, the option will continue to be exercisable until the expiration date set forth in the option agreement, provided that an option may be exercised within one year from the date of death even though beyond the expiration date; and |
(iv) |
if the holder ceases to be a director for any other reason, the option shall terminate and cease to be exercisable 30 days after cessation of service, except in the event of a change in control of Fortune Brands, Inc. |
(i) |
the highest price per share paid for shares of our common stock acquired in the change in control; and |
(ii) |
the highest market value of shares of our common stock during the 60-day period beginning on the date of the change in control. |
10
Section 16(a) Beneficial Ownership Reporting Compliance
11
EXECUTIVE COMPENSATION
Summary Compensation Table
Annual Compensation |
Long-Term Compensation |
|||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Awards |
Payouts |
|||||||||||||||||||||||||||||
Name and Principal Position |
Year |
Salary ($) |
Bonus ($) |
Other Annual Compensa- tion ($)(1) |
Securities Underlying Options/ SARs(#) |
LTIP Payout ($)(2) |
All Other Compensa- tion ($)(3) |
|||||||||||||||||||||||
Norman H.
Wesley Chairman of the Board and Chief Executive Officer |
2003 2002 2001 |
1,000,000 950,000 900,000 |
1,217,200 1,548,000 722,200 |
309,866 359,188 338,871 |
190,000 190,000 190,000 |
3,876,192 1,611,039 721,911 |
270,586 201,300 160,847 |
|||||||||||||||||||||||
Craig P.
Omtvedt Senior Vice President and Chief Financial Officer |
2003 2002 2001 |
515,000 495,000 475,000 |
405,614 521,900 275,000 |
149,107 83,593 126,588 |
95,000 95,000 95,000 |
1,676,467 698,117 510,399 |
113,255 94,496 89,438 |
|||||||||||||||||||||||
Mark A.
Roche Senior Vice President, General Counsel and Secretary |
2003 2002 2001 |
422,000 405,000 390,000 |
302,152 388,200 184,100 |
96,914 81,454 107,270 |
60,000 60,000 60,000 |
1,036,867 429,610 308,068 |
87,668 134,361 119,833 |
|||||||||||||||||||||||
Mark
Hausberg Senior Vice President Finance and Treasurer |
2003 2002 2001 |
305,000 295,000 285,000 |
218,380 282,800 134,500 |
67,796 59,902 44,654 |
28,000 30,000 30,000 |
474,805 198,704 128,767 |
66,120 54,778 43,301 |
|||||||||||||||||||||||
Christopher J. Klein Senior Vice President Strategy and Corporate Development |
2003 | 237,371 | 250,600 | 0 | 60,000 | 339,167 | 23,432 |
Footnotes to Summary Compensation Table
(1) |
The executive officers named above (except for Mr. Klein) are
not covered under the Companys tax qualified defined benefit pension plan and contributions for them to the Companys defined contribution
plan are reduced due to Internal Revenue Code limitations. As such, their pension benefits are provided under our Supplemental Plan and the amounts
that we are not able to contribute on their behalf to our defined contribution plan are also credited to them under the Supplemental Plan. We make
after-tax contributions to trusts to fund these benefits. We also fund the tax withholding associated with these contributions in order to provide the
benefit outlined in the Pension Plan table on page 16. These arrangements have been approved by stockholders. The amount we list above in the Other Annual Compensation column includes the following amounts provided to the executive for tax withholding: |
2003 |
2002 |
2001 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Norman H.
Wesley |
$ | 203,520 | $ | 309,166 | $ | 324,805 | ||||||||
Craig P.
Omtvedt |
103,024 | 48,227 | 102,832 | |||||||||||
Mark A.
Roche |
68,555 | 60,108 | 93,829 | |||||||||||
Mark
Hausberg |
54,679 | 50,980 | 39,027 |
12
Also included in the Other Annual Compensation column for 2003 are the following dividends paid on performance awards under the Companys Long-Term Incentive Plans: $106,346 for Mr. Wesley; $46,083 for Mr. Omtvedt; $28,359 for Mr. Roche and $13,117 for Mr. Hausberg. |
(2) |
The amount we list in the LTIP Payout column is the value of performance awards for the performance period that ended in the year reported. For example, the amount for 2003 includes the performance awards paid in 2004 based upon targets achieved for the 2001-2003 period. Executive officers who meet certain internal share ownership guidelines are eligible to receive the performance awards, which are denominated in shares, in cash. For the award paid in 2004, the full amount was paid in cash to Messrs. Wesley, Omtvedt, Roche and Hausberg. Mr. Klein received his full award in shares. |
(3) |
The amount we list in the All Other Compensation column includes: (a) Company contributions to the tax qualified defined contribution plan of the Company, (b) supplemental profit-sharing amounts under the Companys Supplemental Plan, and (c) the value of premiums paid by the Company under split-dollar life insurance and other life insurance programs. We describe these benefits below. |
(a) |
Defined Contribution Plan Contributions. Company contributions for 2003 to the Companys tax qualified defined contribution plan were $21,980 for each of Messrs. Wesley, Omtvedt, Roche and Hausberg and $18,293 for Mr. Klein. |
(b) |
Supplemental Plan. The Supplemental Plan credits certain
executives with amounts that would have been contributed to their accounts under the profit-sharing formula set forth in our tax qualified defined
contribution plan but could not be contributed because of Internal Revenue Code limitations. Supplemental profit-sharing credits earned under our
Supplemental Plan for 2003 were: $225,828 for Mr. Wesley; $80,493 for Mr. Omtvedt; $58,688 for Mr. Roche; $37,295 for Mr. Hausberg; and $3,594 for Mr.
Klein. In order to fund the Companys obligations to provide these supplemental profit-sharing benefits under the Supplemental Plan, the Company made contributions in 2003 to fund supplemental profit-sharing credits earned for 2002 in the following amounts under trust funding arrangements approved by stockholders: $95,920 for Mr. Wesley; $37,139 for Mr. Omtvedt; $25,351 for Mr. Roche; and $14,955 for Mr. Hausberg. The Company funds only an amount sufficient to provide the expected after-tax profit-sharing benefit. These contributions to the trusts are not listed in the All Other Compensation column, because they were made to fund supplemental profit-sharing credits that are already disclosed in the All Other Compensation column. The Company made additional contributions in 2003 in the following amounts to the trusts to fund its obligations for supplemental pension benefits under the Companys Supplemental Plan: $240,454 for Mr. Wesley, $128,571 for Mr. Omtvedt, $69,288 for Mr. Roche and $60,979 for Mr. Hausberg. These contributions are not listed in the All Other Compensation column because they were made to fund supplemental retirement benefits already disclosed in the Pension Plan table on page 16. |
(c) |
Split-Dollar Life Insurance Program. The Company provides a split-dollar life insurance program for certain executive officers, including Messrs. Wesley, Omtvedt, Roche and Hausberg. All insurance proceeds from the split-dollar life insurance program that exceed the executives death benefit are payable to the Company, and the program is designed for the Company to recover at least its aggregate premium cost. The Company elected to prepay its share of the full premiums for the policies covering the executives identified above in two annual installments when the executives first became covered under the program. Mr. Wesley became covered under the program in 1999 and Messrs. Omtvedt, Roche and Hausberg became covered in 1997. Additional split-dollar life insurance was obtained in 1998 and 2000 for Mr. Omtvedt and in 2001 for Mr. Roche in order to provide for increased death benefits attributable to salary increases. The Companys share of the premiums for the increased insurance obtained for Mr. Omtvedt in 2000 was paid in two annual installments, in 2000 and 2001. The Companys share of the premiums for the insurance obtained for Mr. Roche in 2001 was also paid in two installments, in 2001 and 2002. |
13
The amounts set forth in the All Other Compensation column for 2001 for Messrs. Omtvedt and Roche and for 2002 for Mr. Roche include the dollar value of insurance premiums paid by the Company in those years for split-dollar insurance, as reduced by the projected refund to the Company on the maturity of the policy calculated on an actuarial basis. |
Additional Life Insurance Program. The Company provides an additional life insurance program for certain executive officers, including Messrs. Wesley, Omtvedt, Roche, Hausberg and Klein. The amounts set forth in the All Other Compensation column for 2003 for Messrs. Wesley, Omtvedt, Roche, Hausberg and Klein include the dollar value of insurance premiums paid by the Company in 2003. These amounts are: $21,378 for Mr. Wesley; $9,382 for Mr. Omtvedt; $5,600 for Mr. Roche; $5,445 for Mr. Hausberg; and $1,545 for Mr. Klein. In addition, the amounts set forth in the All Other Compensation column for 2003 include income of $1,400 for each of Messrs. Wesley, Omtvedt, Roche and Hausberg related to reimbursement of long-term disability insurance premiums. |
Option/SAR Grants in Last Fiscal Year
Individual Grants |
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Name |
Number of Securities Underlying Options/SARs Granted (#)(1) |
Percent of Total Options/SARs Granted to Employees in Fiscal Year |
Exercise or Base Price ($/SH) |
Expiration Date(2) |
Grant Date Present Value ($)(3) |
|||||||||||||||||
Norman H.
Wesley |
190,000 |
6.6 |
57.46 | 9/29/13 | 2,553,600 | |||||||||||||||||
Craig P.
Omtvedt |
95,000 |
3.3 |
57.46 | 9/29/13 | 1,276,800 | |||||||||||||||||
Mark A.
Roche |
60,000 |
2.1 |
57.46 | 9/29/13 | 806,400 | |||||||||||||||||
Mark
Hausberg |
28,000 |
1.0 |
57.46 | 9/29/13 | 376,320 | |||||||||||||||||
Christopher J.
Klein |
60,000 |
2.1 |
57.46 | 9/29/13 | 806,400 |
(1) |
All options are for shares of common stock of the Company. No stock appreciation rights (SARs) were granted during 2003. Options are generally not exercisable for one year after the date of grant. The options granted during 2003 become exercisable in three equal annual installments beginning one year after the date of grant. |
(2) |
The 1999 and 2003 Long-Term Incentive Plans provide that each option shall have a limited right (Limited Right) which generally is exercised automatically on the date of change in control of the Company. The Limited Right generally entitles the holder of the option to receive cash equal to the number of shares subject to the option multiplied by the difference between the exercise price per share and (a) the fair market value of such shares at the date of exercise of the Limited Right if the option is an incentive stock option and (b) if the option is a nonqualified stock option, the greater of (i) the highest price per share paid for the shares of common stock of the Company acquired in the change in control and (ii) the highest market value of shares of common stock during a specified period prior to the time of exercise. The option is canceled to the extent of the exercise of the Limited Right. |
(3) |
Grant Date Present Value is determined using the Black-Scholes option pricing model based on the following assumptions: |
(a) |
an expected option term of four and a half years which reflects a reduction of the actual ten-year term of an option based on historical data regarding the average length of time an optionee holds the option before exercising; |
(b) |
a risk-free weighted-average rate of return of 2.81%, the rate of a five-year U.S. Treasury Zero Coupon Bond corresponding to the expected option term; |
14
(c) |
stock price volatility of 29.41% based on daily closing stock market quotations for the period March 1999 to September 2003; and |
(d) |
a yield of 2.1% based on the annual dividend rate of $1.20 per share at the date of grant. |
The Grant Date Present Values in the table are only theoretical values and may not accurately determine present value. The actual value, if any, to be realized by an optionee will depend on the excess of the market value of the common stock over the exercise price on the date the option is exercised. |
Aggregated Option/SAR Exercises in Last Fiscal Year and
Fiscal Year-End
Option/SAR Values(1)
Name |
Shares Acquired on Exercise (#)(1) |
Value Realized ($) |
Number of Securities Underlying Unexercised Options/ SARs at FY-End (#) Exercisable/ Unexercisable |
Value of Unexercised In-The-Money Options/ SARs at FY-End ($) Exercisable/ Unexercisable |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Norman H.
Wesley |
58,593 | 1,798,335 | 603,801/379,999 | 23,719,788/7,999,605 | ||||||||||||||
Craig P.
Omtvedt |
64,826 | 2,531,713 | 154,007/189,999 | 5,228,672/3,999,783 | ||||||||||||||
Mark A.
Roche |
66,016 | 2,123,911 | 148,944/120,000 | 5,767,997/2,526,200 | ||||||||||||||
Mark
Hausberg |
37,250 | 1,387,787 | 124,271/58,000 | 4,794,228/1,235,040 | ||||||||||||||
Christopher
J. Klein |
0 | 0 | 0/60,000 | 0/841,800 |
(1) |
No SARs were exercised during 2003 and no SARs were outstanding as of February 2, 2004. |
Long-Term Incentive Plan Awards in Last Fiscal Year
Performance
Period 20042006
Estimated Future Payouts Under Non-Stock Price-Based Plans |
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Name |
Number of Shares, Units or Other Rights (#)(1) |
Performance or Other Period Until Maturation or Payout |
Threshold (#) |
Target (#) |
Maximum (#) |
||||||||||||||||||
Norman H.
Wesley |
40,000 |
3
yrs. |
20,000 | 40,000 | 60,000 | ||||||||||||||||||
Craig P.
Omtvedt |
16,500 |
3
yrs. |
8,250 | 16,500 | 24,750 | ||||||||||||||||||
Mark A.
Roche |
10,500 |
3
yrs. |
5,250 | 10,500 | 15,750 | ||||||||||||||||||
Mark
Hausberg |
4,000 |
3
yrs. |
2,000 | 4,000 | 6,000 | ||||||||||||||||||
Christopher J.
Klein |
10,500 |
3
yrs. |
5,250 | 10,500 | 15,750 |
(1) |
Performance share awards were granted for the January 1, 2004December 31, 2006 performance period. These figures represent the number of shares that will be awarded upon attainment of the average consolidated return on equity and cumulative increase in diluted earnings per share targets for the performance period 2004-2006. |
15
target amount. The threshold amount will be earned at the achievement of approximately 90% of the targeted average consolidated return on equity and cumulative diluted earnings per share. In addition, cash dividend equivalents will be paid, but only to the extent that the performance goals are achieved.
Retirement Plans
Pension Plan Table Estimated Annual Retirement Benefits for Representative Years of Credited Service |
|||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Remuneration |
10 |
15 |
20 |
25 |
30 |
35 |
|||||||||||||||||||||
$ 500,000 |
$ | 87,500 | $ | 131,250 | $ | 156,250 | $ | 187,500 | $ | 225,000 | $ | 262,500 | |||||||||||||||
600,000 |
105,000 | 157,500 | 187,500 | 225,000 | 270,000 | 315,000 | |||||||||||||||||||||
700,000 |
122,500 | 183,750 | 218,750 | 262,500 | 315,000 | 367,500 | |||||||||||||||||||||
800,000 |
140,000 | 210,000 | 250,000 | 300,000 | 360,000 | 420,000 | |||||||||||||||||||||
900,000 |
157,500 | 236,250 | 281,250 | 337,500 | 405,000 | 472,500 | |||||||||||||||||||||
1,000,000 |
175,000 | 262,500 | 312,500 | 375,000 | 450,000 | 525,000 | |||||||||||||||||||||
1,100,000 |
192,500 | 288,750 | 343,750 | 412,500 | 495,000 | 577,500 | |||||||||||||||||||||
1,200,000 |
210,000 | 315,000 | 375,000 | 450,000 | 540,000 | 630,000 | |||||||||||||||||||||
1,300,000 |
227,500 | 341,250 | 406,250 | 487,500 | 585,000 | 682,500 | |||||||||||||||||||||
1,400,000 |
245,000 | 367,500 | 437,500 | 525,000 | 630,000 | 735,000 | |||||||||||||||||||||
1,600,000 |
280,000 | 420,000 | 500,000 | 600,000 | 720,000 | 840,000 | |||||||||||||||||||||
1,800,000 |
315,000 | 472,500 | 562,500 | 675,000 | 810,000 | 945,000 | |||||||||||||||||||||
2,000,000 |
350,000 | 525,000 | 625,000 | 750,000 | 900,000 | 1,050,000 | |||||||||||||||||||||
2,200,000 |
385,000 | 577,500 | 687,500 | 825,000 | 990,000 | 1,155,000 | |||||||||||||||||||||
2,400,000 |
420,000 | 630,000 | 750,000 | 900,000 | 1,080,000 | 1,260,000 | |||||||||||||||||||||
2,600,000 |
455,000 | 682,500 | 812,500 | 975,000 | 1,170,000 | 1,365,000 | |||||||||||||||||||||
16
of the Internal Revenue Code limit on the amount of annual benefits that may be paid from a tax qualified Retirement Plan. The current Internal Revenue Code limit is the lesser of $165,000 or the employees average annual compensation during the three highest-paid consecutive years of employment. The Internal Revenue Code also provides that benefits under tax qualified plans cannot be based on compensation in excess of a certain limit, currently $205,000. The Supplemental Plan provides the difference between the amount paid under our tax qualified plans and the amount that would have been paid if the limit on compensation were not included therein. In calculating benefits, no credit is given for service in excess of 35 years.
(i) |
three years of base salary, three times the amount of his annual incentive compensation award and defined contribution plan allocation (and the supplemental profit-sharing allocation under the Supplemental Plan); |
(ii) |
three additional years of service and earnings credit under our retirement plans and agreements; and |
(iii) |
three additional years of coverage under our life, health, accident, disability and other employee plans. |
Report of the Compensation and Stock Option Committee on Executive Compensation
(i) |
competitive levels of salary and total compensation; |
(ii) |
annual incentive compensation that varies with the annual financial performance of the Company and its various operating companies established for each executive; and |
(iii) |
long-term incentive compensation to reward long-term financial performance. |
17
derives the competitive information from a variety of sources, including surveys of compensation awarded by large, publicly-held corporations. Hewitt Associates, the outside consultant of the Compensation and Stock Option Committee (the Committee), and Towers Perrin conducted these surveys. Most of the companies in the survey group are in the S&P 500 and some are in the Peer Group Index described on pages 20 and 21. The Committee relies on a broad array of companies for comparative analysis of executive compensation because it believes that the Companys competitors for executive talent are more varied than the Peer Group.
Committee Responsibilities
Base Salaries
Annual Incentive Bonuses
(i) |
eliminate restructuring charges or credits; |
(ii) |
eliminate other nonrecurring charges or credits, as disclosed in the audited financial statements and notes; |
(iii) |
include the results of operations for such year from businesses classified as discontinued operations prior to the disposition dates; and |
(iv) |
to the extent not adjusted pursuant to the above items, eliminate gains or losses resulting from the sale, disposal or writedown of intangible assets, land or buildings, charges for impaired assets, businesses, securities resulting from the sale of businesses and the sale of financial instruments. |
18
Long-Term Incentives
19
equity and cumulative diluted earnings per share are achieved. An additional amount of shares will be paid if the targeted goals are exceeded, but the maximum number of shares paid will not exceed 150% of the target amount. In addition, the recipients of these performance awards will receive cash dividend equivalents at the time of payment equal to the cash dividends that would have been paid on the shares had the recipient owned the shares during the performance period. The executive officers have the option to receive their performance share awards in cash if they have met the Companys goals for Company stock ownership.
February 23, 2004
FORTUNE BRANDS, INC. STOCK PRICE PERFORMANCE
(With Dividend
Reinvestment)
20
Peer Group Index
(1) |
the total return of each Peer Group member is calculated by dividing the change in market value of a share of its common stock, assuming periodic dividend reinvestment, by the cumulative value of a share of its common stock at the beginning of the year; |
(2) |
each Peer Group members total return is then weighted within its industry segment based on its market capitalization at the beginning of the year, relative to the market capitalization of the entire segment, and the sum of such weighted returns results in a weighted average total return for that segment; and |
(3) |
each segments weighted average total return is then weighted based on the percentage of sales, excluding excise taxes, of that segment of the Company for the year, as compared with total Company sales, excluding excise taxes, and the sum of such weighted returns results in a weighted average total return for the entire Peer Group. |
Report of the Audit Committee
21
independent auditor has provided an unqualified opinion regarding the Companys financial statements for the year ended December 31, 2003.
February 23, 2004
Audit Fees
Audit Related Fees
Tax Fees
22
All Other Fees
Approval of Audit and Non-Audit Services
Item 2
RATIFICATION OF APPOINTMENT OF INDEPENDENT AUDITORS
The Board of Directors recommends that you vote FOR Item 2.
Item 3
SHAREHOLDER VOTE ON POISON PILLS
3 Shareholder Voting Right on a Poison Pill
RESOLVED: That the shareholders of our company request that our Board of Directors seek shareholder approval at the earliest subsequent shareholder election, for the adoption, maintenance or extension of any current or future poison pill. Once adopted, removal of this proposal or any dilution of this proposal, would consistently be submitted to shareholder vote at the earliest subsequent shareholder election.
23
We as shareholders voted in support of this topic:
Year |
Rate of Support |
|||||
---|---|---|---|---|---|---|
2002 |
65 | % | ||||
2003 |
63 | % |
This percentage is based on yes and no votes cast. I believe this level of shareholder support is more impressive because the 63% support followed our Directors objection to the proposal. I believe that there is a greater tendency for shareholders, who more closely follow our company, to vote in favor of this proposal topic. I do not see how our Directors object to this proposal because it gives our Directors the flexibly (sic) to override our shareholder vote if our Directors seriously believes (sic) they have a good reason. This topic also won an overall 60% yes-vote at 79 companies in 2003.
Nick Rossi, P.O. Box 249, Boonville, Calif. 95415 submitted this proposal.
Putting poison pills to a vote is a way of affirming the central role that shareholders should play in the life of a corporation. An anti-democratic scheme to flood the market with diluted stock is not a reason that a tender offer for our stock should fail.
The key negative of poison pills is that pills can preserve management deadwood instead of protecting investors.
Hectoring directors to act more independently is a poor substitute for the bracing possibility that shareholders could turn on a dime and sell the company out from under its present management.
Poison pills are akin to a dictator who says, Give up more of your freedom and Ill take care of you.
Performance is the greatest defense against getting taken over. Ultimately if you perform well you remain independent, because your stock price stays up.
I believe our board may be tempted to partially implement this proposal to gain points in the new corporate governance scoring systems. I do not believe that a token response, which could still allow our directors to give us a poison pill on short notice, would be a substitute for complete implementation.
The Council of Institutional Investors www.cii.org, an organization of 130 pension funds investing $2 trillion, called for shareholder approval of poison pills. Based on the 60% overall yes-vote in 2003 many shareholders believe companies should allow their shareholders a vote.
Shareholder Voting Right on Poison Pill
Yes on 3
Board of Directors Statement: Recommends Vote AGAINST Item
3
24
|
The Rights Plan enhances stockholder value in the event of a proposed hostile takeover of the Company. As evidenced by the Companys performance, the Board of Directors has demonstrated a strong track record of maximizing stockholder value. Unfortunately, the stockholders proposal could seriously weaken the Companys negotiating position in a hostile situation and leave us less able to maximize stockholder value. |
|
The Rights Plan gives the Board flexibility to prevent coercive takeover tactics, discourage inadequate offers and identify higher bidders, while not precluding a takeover offer. |
|
Multiple studies have concluded that shareholders of firms with rights plans receive higher takeover premiums than those without such plans. |
|
Many companies see rights plans as an important shareholder protection. More than half of S&P 500 companies maintain rights plans. |
|
The Board has responded to shareholder concerns by initiating regular, independent review of the Companys Rights Plan. |
Rights Plan Enhances Stockholder Value in the Event of Hostile Takeover Attempt
|
creeping accumulations of stock that dont provide stockholders with a control premium and relegate stockholders to a minority position; |
|
partial tender offers (under which a bidder acquires only a controlling interest and no more); and |
|
two-tiered tender offers (which pay a certain price for a controlling interest and a lower price for the remainder of the companys stock); |
The Rights Plan also provides the Board with additional time to develop alternatives to maximize value, such as identifying higher bidders. Finally, the Rights Plan discourages inadequate and insufficient offers and encourages the bidder to negotiate with the Board so that it may assure that all stockholders receive full value. For example, if the Company had not maintained a rights plan and had a hostile acquirer made a successful tender offer for the Companys stock at its 52-week low in the year 2000, stockholders would not have benefited from a tripling of the Companys stock price since that time.
Studies Demonstrate that Rights Plans Add Stockholder Value
|
rights plans contributed an additional $13 billion in stockholder value and stockholders of acquired companies without rights plans gave up $14.5 billion in potential premiums; and |
|
rights plans did not reduce the likelihood of a company becoming a takeover target and the presence of a rights plan did not increase the likelihood of withdrawal of a friendly takeover bid nor the defeat of a hostile one. |
25
Board has Been Responsive to Stockholder Concerns
Stockholder Proposal Counterproductive, Should be Defeated
The Board recommends that you vote AGAINST Item 3.
CERTAIN INFORMATION REGARDING SECURITY HOLDINGS
Name |
Amount and Nature of Beneficial Ownership (1)(2)(3) |
Percent of Class |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
Barclays
Global Investors, NA. (a) |
12,161,543 | 8.30 | % | |||||||
Patricia O.
Ewers |
22,731 | * | ||||||||
Mark
Hausberg |
146,236 | * | ||||||||
Thomas C.
Hays |
410,720 | * | ||||||||
Christopher
J. Klein |
2,916 | * | ||||||||
Pierre E.
Leroy |
100 | * | ||||||||
Gordon R.
Lohman |
19,217 | * | ||||||||
Craig P.
Omtvedt |
198,713 | * | ||||||||
Eugene A.
Renna |
14,465 | * | ||||||||
J.
Christopher Reyes |
7,192 | * | ||||||||
Mark A.
Roche |
193,598 | * | ||||||||
Anne M.
Tatlock |
22,949 | * | ||||||||
David M.
Thomas |
11,725 | * | ||||||||
Norman H.
Wesley |
723,748 | * | ||||||||
Peter M.
Wilson |
19,872 | * | ||||||||
Directors and
executive officers as a group (15) persons |
1,808,632 | 1.23 | % |
26
* |
Less than 1% |
(a) |
To the best of our knowledge, no one person was the beneficial owner of more than 5% of the outstanding voting securities of the Company or more than 5% of any class of voting securities of the Company on February 2, 2004, except that, based on a Schedule 13G filed with the Securities Exchange Commission, Barclays Global Investors, NA., together with certain entities that filed a Joint Acquisition Statement on Schedule 13G, reported beneficial ownership on December 31, 2003 of 12,161,543 shares of common stock with the sole voting power for 10,713,984 shares. The address of Barclays Global Investors, NA. is 45 Fremont Street, San Francisco, California 94105. The filing entities reported that the shares were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing control. |
(1) |
No individual director or nominee for director or executive officer beneficially owns one percent or more of the outstanding equity securities of the Company. To the best of our knowledge, each nominee and Class I and II director and executive officer who is not a director has sole voting and investment power with respect to shares shown above, other than with respect to the shares listed in Note (3) below that may be acquired upon exercise of options, and except as follows: Mr. Hays shares voting and investment power as a co-trustee of various family trusts with respect to 9,907 shares and with respect to which shares he disclaims beneficial ownership, and Mr. Hays has no voting or investment power with respect to 54,802 shares held in trust for the benefit of his wife and with respect to which shares he disclaims beneficial ownership. |
(2) |
The numbers of shares attributable to Company contributions under the Companys Retirement Savings Plan (RSP) included in the numbers shown above are as follows: Mark Hausberg, 1,136; Thomas C. Hays, 1,087; Craig P. Omtvedt, 1,275; and Mark A. Roche, 3,639. The numbers of shares attributable to employee contributions under the RSP included in the numbers shown above are: Thomas C. Hays, 2,924; Craig P. Omtvedt, 1,198; and Mark A. Roche, 1,784. The Trustee of the RSP has agreed to vote the shares it holds in the Trust in accordance with instructions received from members of the RSP and shares as to which instructions are not received are voted by the Trustee proportionally in the same manner as shares as to which the Trustee has received instructions. The number shown in the table above includes 13,043 shares of common stock held February 2, 2004 by the Trustee of the RSP (including certain of those referred to above) which number is equivalent as of that date to the undivided proportionate beneficial interests of the directors and executive officers of the Company in all such shares. |
(3) |
The director nominees, Class I and II directors and Messrs. Hausberg, Omtvedt and Roche had the right to acquire beneficial ownership pursuant to the exercise on or before April 2, 2004 of options granted by the Company of the following number of shares: Patricia O. Ewers, 17,717; Mark Hausberg, 124,271; Thomas C. Hays, 342,000; Gordon R. Lohman, 17,717; Craig P. Omtvedt, 154,007; Eugene A. Renna, 5,000; J. Christopher Reyes, 3,542; Mark A. Roche, 148,944; David M. Thomas, 9,375; Norman H. Wesley, 603,801; and Peter M. Wilson, 14,500. The number of shares shown in the table above includes 1,458,591 shares of which the directors and executive officers as a group had the right to acquire beneficial ownership pursuant to the exercise on or before April 2, 2004 of options granted by the Company. Inclusion of such shares does not constitute an admission by any nominee, director or executive officer that he or she is the beneficial owner of such shares. |
27
SUBMISSION OF STOCKHOLDER PROPOSALS AND NOMINATIONS
What governs stockholder proposals and nominations?
Who can make a nomination?
How do I go about making a nomination?
|
the names and addresses of you and any other stockholder who intends to appear in person or by proxy to make the nomination, and the name and address of the person(s) to be nominated; |
|
a description of all arrangements or understandings between you and each nominee and any other person(s) (naming them) pursuant to which the nomination is to be made; |
|
any other information regarding each of your proposed nominees that would be included in a proxy statement; and |
|
the consent of each nominee to serve if elected. |
Who can make a proposal?
How do I go about making a proposal?
|
a brief description of the business to be brought before the meeting, the reasons for conducting the business and any material interest that you or the beneficial owners, if any, on whose behalf you are making the proposal may have in the business; |
|
your name and address, and the names and addresses of the beneficial owners, if any, on whose behalf you are making the proposal, as they appear on our books; and |
|
the class and number of shares of our stock that are owned beneficially and of record by you and the beneficial owners. |
28
MISCELLANEOUS
Multiple Stockholders Having the Same Address
March 12, 2004
29
EXHIBIT A
FORTUNE BRANDS, INC.
AUDIT COMMITTEE CHARTER
Purpose
The purpose of the Audit Committee is to assist the Board of Directors (Board) in overseeing (1) the integrity of the financial statements and the financial reporting process of the Company, (2) compliance by the Company with legal and regulatory requirements, (3) independence and qualifications of the Companys external auditors and (4) performance of the Companys external and internal auditors.
Membership
The Committee shall be composed of not less than three directors, each of whom meets the independence and experience requirements of the New York Stock Exchange listing rules and the independence standard set forth in Rule 10 A-3 under the Securities Exchange Act of 1934. The members shall be appointed by the Board on the recommendation of the Nominating and Corporate Governance Committee.
Authority and Responsibilities
The Audit Committee shall:
Independent Auditors
| Retain (subject to shareholder ratification) a firm of independent certified public accountants to serve as the Companys principal independent auditors. The independent auditors are accountable to the Audit Committee, which has the ultimate authority and responsibility to appoint and retain (subject to shareholder approval), evaluate and terminate the auditors. |
| Approve the scope of audit work and review the reports and recommendations of the Companys principal independent auditors, as well as their performance of requested services. |
| Discuss with the independent auditors the matters required to be discussed by Statement on Auditing Standards number 61 including: the auditors responsibilities, difficulties and problems encountered in performing the audit, including any restrictions on the scope of the independent auditors activities or on access to requested information and managements response. |
| Discuss with the independent auditors the annual audited financial statements and quarterly financial statements, including the Companys disclosures under Managements Discussion and Analysis of Financial Condition and Results of Operations. |
| Discuss with the auditors the auditors independence and obtain the letter required by the Independence Standards Board Standard No. 1 confirming the auditors independence. |
| Review annually a written report prepared by the independent auditors describing: |
1. |
the firms internal quality-control procedures; |
2. |
any material issues raised by the most recent internal quality-control review, or peer review, of the independent auditors, or by a governmental or professional authority investigation or inquiry within the past five years with respect to independent audits carried out by the auditors, along with any steps taken to deal with such issues; and |
3. |
all relationships between the independent auditors and the Company and how those relationships affect the auditors independence. |
A-1
| Approve all non-audit services performed by the independent auditors. |
| Meet separately with independent auditors (without the presence of management) on a quarterly basis. |
Management
| Discuss the following with management: |
1. |
the annual audited financial statements and quarterly financial statements, including the Companys disclosures under Managements Discussion and Analysis of Financial Condition and Results of Operations; |
2. |
major issues regarding accounting and auditing principles and practices, including all critical accounting policies; |
3. |
the adequacy of internal controls and procedures that are used to ensure the accuracy and completeness of the Companys financial statements; |
4. |
the quarterly certifications by the Chief Executive Officer and Chief Financial Officer regarding the accuracy and completeness of the Companys financial statements and Securities and Exchange Commission (SEC) reports and the adequacy of internal controls and procedures; and |
5. |
the Companys press releases and conference call scripts with respect to earnings announcements, as well as financial information and earnings guidance provided to analysts and rating agencies. |
| Review the Companys policies with respect to risk assessment and risk management. Discuss the Companys major financial risk exposures and the steps management has taken to monitor and control such exposures. |
| Meet separately with management on a quarterly basis. |
Internal Auditors
| Approve the annual internal audit plan and receive quarterly updates on the results of internal audit work. |
| Review internal audit staffing levels and qualifications, annual expense budgets, and any changes in the duties of the Chief Internal Auditor. |
| Meet separately with the Chief Internal Auditor on a quarterly basis. |
Other Responsibilities
| Review the findings resulting from any examinations of the Companys financial statements by federal regulatory agencies, including the SEC and the Internal Revenue Service. |
| Review the activities of the Corporate Compliance Committee and its annual report regarding Company-wide compliance programs. |
| Establish procedures for the receipt, retention and treatment of complaints regarding accounting, internal accounting controls, or auditing matters, including creation of mechanisms for the confidential, anonymous submission of complaints. |
| Establish hiring policies for employees or former employees of the independent auditor. |
| Retain outside legal, accounting, or other advisors as deemed appropriate by a majority of the members of the Audit Committee or the Chairman of the Audit Committee. |
| Prepare a report to be included in the Companys annual proxy statement disclosing whether the Audit Committee has recommended to the Board that the audited financial statements be included in the Companys Form 10-K, as required by the rules of the SEC. |
| Report Committee findings to the Board on a regular basis and make such recommendations to the Board as deemed appropriate. |
A-2
| Perform such other duties in connection with the Companys financial reporting, audit procedures and system of internal control as are requested from time to time by the Board. |
| Review and reassess the adequacy of this Charter annually, submit it to the Board for approval, and disclose in the Companys annual proxy statement that the Committee has a written charter. |
| Annually evaluate the performance of the Audit Committee and report the results of this evaluation to the Board. |
While the Audit Committee has the responsibilities and powers set forth in this Charter, management has the responsibility for the Companys system of internal control and the financial reporting process. The independent auditors have the responsibility to conduct an independent audit in accordance with generally accepted auditing standards and to issue an opinion thereon. The Audit Committees responsibility is to monitor and oversee these processes.
A-3
AUTO DATA
PROCESSING |
VOTE
BY INTERNET - www.proxyvote.com VOTE
BY PHONE - 1-800-690-6903 VOTE
BY MAIL |
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: x | FORTN1 | KEEP THIS PORTION FOR YOUR RECORDS |
DETACH AND RETURN THIS PORTION ONLY | ||
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. |
FORTUNE BRANDS INC. | |||||||||||||
THE
BOARD OF DIRECTORS RECOMMENDS VOTES FOR ITEMS 1 AND 2 AND AGAINST ITEM 3: |
|||||||||||||
Vote On Directors | For All |
Withhold All |
For
All Except |
To
withhold authority to vote for any individual nominee, mark "For
All Except" and write the nominee's number on the line below. |
|||||||||
1. | Election of Directors. | ||||||||||||
Nominees: | 01) Anne M.
Tatlock 02) Norman H. Wesley 03) Peter M. Wilson |
o | o | o | |||||||||
Vote On Proposals | For | Against | Abstain | |||||||
2. | Ratify the election of PricewaterhouseCoopers LLP as independent auditors for 2004. | o | o | o | ||||||
3. | Stockholder Proposal entitled "Shareholder Vote on Poison Pills" to adopt the following resolution: | For | Against | Abstain | ||||||
"The
shareholders of our company request that our Board of Directors seek
shareholder approval at the earliest subsequent shareholder election,
for the adoption, maintenance or extension of any current or future
poison pill. Once adopted, removal of this proposal or any dilution
of this proposal, would consistently be submitted to shareholder vote
at the earliest subsequent shareholder election." |
o | o | o |
Please Sign, Date and Return the Proxy Promptly Using the Enclosed Envelope.
For address changes and/or comments, please check this box and write them on the back where indicated. Note: Please sign as your name appears. If shares are held by joint tenants, both should sign. When signing as attorney, executor, administrator, trustee or guardian, please give your full title as such. If a corporation, please sign in full corporate name by authorized officer. If a partnership, please sign in full partnership name by authorized person. |
o | AUTO
DATA PROCESSING |
Signature [PLEASE SIGN WITHIN BOX] | Date | Signature (Joint Owners) | Date |
Website available 24 hours a day, 7 days a week
E L E C T R O N I C D E L I V E R Y |
Reduce
paper mailed to your home and help lower Fortune Brands is pleased to offer the convenience of viewing Proxy Statements, Annual Reports to Stockholders and related materials on-line. With your consent, we can stop sending paper copies of these documents beginning next year and until you notify us otherwise. To participate, follow the easy directions on the right. You will receive notification when the materials are available for review. |
(1) Log
onto the Internet at (2) Enter
your Social Security or Tax I.D. (3) Enter your e-mail address (4) Enter
a PIN number of your choice |
Reminder: Electronic
Voting is also available.
You may vote by telephone or over the Internet.
Voting electronically is quick, easy, and also saves the company money.
Just follow the instructions on your Proxy Card.
FORTUNE BRANDS, INC. PROXY SOLICITED BY THE BOARD OF DIRECTORS The undersigned stockholder appoints N.H. WESLEY, C.P. OMTVEDT, and M.A. ROCHE (and any other person chosen by Messrs. Wesley, Omtvedt or Roche) proxies, to vote at the Annual Meeting (including adjournments) of stockholders of Fortune Brands, Inc. to be held April 27, 2004 at the Marriott Lincolnshire, 10 Marriott Drive, Lincolnshire, Illinois at 1:30 P.M., for the election of nominees Anne M. Tatlock, Norman H. Wesley and Peter M. Wilson, as Class III directors (item 1), on items 2 and 3 referred to on the reverse side and described in the Proxy Statement, and on any other business before the meeting, with all powers the stockholder would possess if personally present. A majority of the proxies (or, if only one, then that one) or their substitutes acting at the meeting may exercise all powers hereby conferred. This proxy when properly executed will be voted in the manner directed by the stockholder. Unless the stockholder indicates otherwise, the proxies will vote FOR the election of the nominees of the Board of Directors (item 1), FOR item 2 and AGAINST item 3. If you participate
in the Fortune Brands Stock Fund under a retirement savings trust, your
signature on the reverse side will be a direction to the trustee to vote
as instructed. |
FORTUNE BRANDS, INC. P.O. BOX 11010 NEW YORK, N.Y. 10203-0010 |
Address Change/Comments: |
|||
(If you noted any address changes/comments above, please mark corresponding box on the other side.) |
(Continued And To Be Signed On Other Side.)
PLEASE EXECUTE AND RETURN YOUR PROXY PROMPTLY